Voltage-gated sodium channels mutations and their role in epilepsy

Andrzej Patyra; Grzegorz Witkowski

doi:10.56782/pps.1

Data publikacji : 2022-06-09

Tom 20 Nr 1 (2022)

Voltage-gated sodium channels mutations and their role in epilepsy

Andrzej Patyra

Grzegorz Witkowski

DOI: https://doi.org/10.56782/pps.1

Abstrakt

Voltage-gated ion channels play a pivotal role in cell signaling. They are responsible for generating action potential and repolarization. For this reason, dysfunctions of these channels are more and more often associated with the occurrence of both congenital and acquired neurological diseases, such as epilepsies, migraines, ataxias, or neuromyotonia. Clinical symptoms of neuronal ion channel dysfunction differ significantly, reflecting the role and distribution of a given channel in the central and peripheral nervous systems. This paper re-views voltage-gated sodium channel structure, physiology, mutations, and their role in epilepsy.

Inne teksty tego samego autora

Katarzyna Kozon, Małgorzata Krzyżanowska, Jakub Olszewski, Andrzej Patyra, Spinal muscular atrophy – the effectiveness of treatment and new therapeutic possibilities for selected groups of patients in Poland , Prospects in Pharmaceutical Sciences: Tom 21 Nr 2 (2023)
Jakub Olszewski, Katarzyn Kozon, Andrzej Patyra, Flozins in heart failure – a new reimbursement indication , Prospects in Pharmaceutical Sciences: Tom 20 Nr 1 (2022)
Andrzej Patyra, Marcin Kołakowski, Marta Katarzyna Dudek, Anna Karolina Kiss, Isolation of trachelogenin 4-O-β-D-glucoside from the fruits of Carthamus tinctorius L. , Prospects in Pharmaceutical Sciences: Tom 20 Nr 2 (2022)
Małgorzata Krzyżanowska, Katarzyna Kozon, Jakub Olszewski, Andrzej Patyra, Efficacy of satralizumab therapy in the treatment of NMOSD , Prospects in Pharmaceutical Sciences: Tom 21 Nr 3 (2023)
Andrzej Patyra, Twenty years of Prospects in Pharmaceutical Sciences: recent changes , Prospects in Pharmaceutical Sciences: Tom 21 Nr 3 (2023)

Podobne artykuły

Dominika Winiarz, Kamila Domańska, Kinga Paluch, Dorota Dorota Skrajnowska, PROBIOTYKI A ZDROWIE - DZIŚ I JUTRO , Prospects in Pharmaceutical Sciences: Tom 15 Nr 10 (2017)
Saffalya Nayak, Pratima Kumari Sahu, Roma Rattan, Srikrushna Mahapatra, Debjyoti Mohapatra, Irisin levels in type 2 diabetes mellitus with and without non-alcoholic fatty liver disease: a case-control study , Prospects in Pharmaceutical Sciences: Tom 22 Nr 3 (2024)

<< < 1 2

Możesz również Rozpocznij zaawansowane wyszukiwanie podobieństw dla tego artykułu.

Szczegóły

Bibliografia

Statystyki

Autorzy

Pobierz pliki

PDF (English)

Zasady cytowania

Patyra, A., & Witkowski, G. (2022). Voltage-gated sodium channels mutations and their role in epilepsy. Prospects in Pharmaceutical Sciences, 20(1), 11–18. https://doi.org/10.56782/pps.1

Wskaźniki altmetryczne

Cited by / Share

Licencja

Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa 4.0 Międzynarodowe.

Bibliografia

Hanna, M.G. Genetic neurological channelopathies. Nat Clin Pract Neurol 2006, 2, 252-263, doi:10.1038/ncpneuro0178. DOI: https://doi.org/10.1038/ncpneuro0178

Reid, C.A.; Berkovic, S.F.; Petrou, S. Mechanisms of human inherited epilepsies. Prog Neurobiol 2009, 87, 41-57, doi:10.1016/j.pneurobio.2008.09.016. DOI: https://doi.org/10.1016/j.pneurobio.2008.09.016

Kullmann, D.M. Neurological channelopathies. Annu Rev Neurosci 2010, 33, 151-172, doi:10.1146/annurev-neuro-060909-153122 DOI: https://doi.org/10.1146/annurev-neuro-060909-153122

Tomlinson, S.E.; Tan, S.V.; Kullmann, D.M.; Griggs, R.C.; Burke, D.; Hanna, M.G.; Bostock, H. Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1. Brain 2010, 133, 3530-3540, doi:10.1093/brain/awq318. DOI: https://doi.org/10.1093/brain/awq318

Kiernan, M.C.; Krishnan, A.V.; Lin, C.S.-Y.; Burke, D.; Berkovic, S.F. Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability. Brain 2005, 128, 1841-1846, doi:10.1093/brain/awh520. DOI: https://doi.org/10.1093/brain/awh520

Scheffer, I.E.; Berkovic, S.F. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997, 120 ( Pt 3), 479-490, doi:10.1093/brain/120.3.479. DOI: https://doi.org/10.1093/brain/120.3.479

Singh, R.; Scheffer, I.E.; Crossland, K.; Berkovic, S.F. Generalized epilepsy with febrile seizures plus: a common childhoodonset genetic epilepsy syndrome. Ann Neurol 1999, 45, 75-81, doi:10.1002/1531-8249(199901)45:1<75::aid-art13>3.0.co;2-w. DOI: https://doi.org/10.1002/1531-8249(199901)45:1<75::AID-ART13>3.0.CO;2-W

Wallace, R.H.; Wang, D.W.; Singh, R.; Scheffer, I.E.; George, A.L., Jr.; Phillips, H.A.; Saar, K.; Reis, A.; Johnson, E.W.; Sutherland, G.R.; et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet 1998, 19, 366-370, doi:10.1038/1252. DOI: https://doi.org/10.1038/1252

Escayg, A.; MacDonald, B.T.; Meisler, M.H.; Baulac, S.; Huberfeld, G.; An-Gourfinkel, I.; Brice, A.; LeGuern, E.; Moulard, B.; Chaigne, D.; et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 2000, 24, 343-345, doi:10.1038/74159. DOI: https://doi.org/10.1038/74159

Abou-Khalil, B.; Ge, Q.; Desai, R.; Ryther, R.; Bazyk, A.; Bailey, R.; Haines, J.L.; Sutcliffe, J.S.; George, A.L., Jr. Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation. Neurology 2001, 57, 2265-2272, doi:10.1212/wnl.57.12.2265. DOI: https://doi.org/10.1212/WNL.57.12.2265

Wallace, R.H.; Scheffer, I.E.; Barnett, S.; Richards, M.; Dibbens, L.; Desai, R.R.; Lerman-Sagie, T.; Lev, D.; Mazarib, A.; Brand, N.; et al. Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet 2001, 68, 859-865, doi:10.1086/319516. DOI: https://doi.org/10.1086/319516

Sugawara, T.; Tsurubuchi, Y.; Agarwala, K.L.; Ito, M.; Fukuma, G.; Mazaki-Miyazaki, E.; Nagafuji, H.; Noda, M.; Imoto, K.; Wada, K.; et al. A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci U S A 2001, 98, 6384-6389, doi:10.1073/pnas.111065098. DOI: https://doi.org/10.1073/pnas.111065098

de Lera Ruiz, M.; Kraus, R.L. Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications. J Med Chem 2015, 58, 7093-7118, doi:10.1021/jm501981g. DOI: https://doi.org/10.1021/jm501981g

Voltage Gated Sodium Channels; Ruben, P.C., Ed.; Springer Berlin: Heidelberg, 2014; p. 295.

Nardi, A.; Damann, N.; Hertrampf, T.; Kless, A. Advances in targeting voltage-gated sodium channels with small molecules. ChemMedChem 2012, 7, 1712-1740, doi:10.1002/cmdc.201200298. DOI: https://doi.org/10.1002/cmdc.201200298

Hodgkin, A.L.; Huxley, A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol 1952, 117, 500-544, doi:10.1113/jphysiol.1952.sp004764. DOI: https://doi.org/10.1113/jphysiol.1952.sp004764

Agnew, W.S.; Levinson, S.R.; Brabson, J.S.; Raftery, M.A. Purification of the tetrodotoxin-binding component associated with the voltage-sensitive sodium channel from Electrophorus electricus electroplax membranes. Proc Natl Acad Sci U S A 1978, 75, 2606-2610, doi:10.1073/pnas.75.6.2606. DOI: https://doi.org/10.1073/pnas.75.6.2606

Watanabe, E.; Fujikawa, A.; Matsunaga, H.; Yasoshima, Y.; Sako, N.; Yamamoto, T.; Saegusa, C.; Noda, M. Nav2/NaG channel is involved in control of salt-intake behavior in the CNS. J Neurosci 2000, 20, 7743-7751, doi:10.1523/jneurosci.20-20-07743.2000. DOI: https://doi.org/10.1523/JNEUROSCI.20-20-07743.2000

Catterall, W.A.; Goldin, A.L.; Waxman, S.G. International Union of Pharmacology. XLVII. Nomenclature and structurefunction relationships of voltage-gated sodium channels. Pharmacol Rev 2005, 57, 397-409, doi:10.1124/pr.57.4.4. DOI: https://doi.org/10.1124/pr.57.4.4

Goldin, A.L. Diversity of mammalian voltage-gated sodium channels. Ann N Y Acad Sci 1999, 868, 38-50, doi:10.1111/j.1749-6632.1999.tb11272.x. DOI: https://doi.org/10.1111/j.1749-6632.1999.tb11272.x

Catterall, W.A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 2000, 26, 13-25, doi:10.1016/s0896-6273(00)81133-2. DOI: https://doi.org/10.1016/S0896-6273(00)81133-2

Pless, S.A.; Elstone, F.D.; Niciforovic, A.P.; Galpin, J.D.; Yang, R.; Kurata, H.T.; Ahern, C.A. Asymmetric functional contributions of acidic and aromatic side chains in sodium channel voltage-sensor domains. J Gen Physiol 2014, 143, 645-656, doi:10.1085/jgp.201311036. DOI: https://doi.org/10.1085/jgp.201311036

Payandeh, J.; Scheuer, T.; Zheng, N.; Catterall, W.A. The crystal structure of a voltage-gated sodium channel. Nature 2011, 475, 353-358, doi:10.1038/nature10238. DOI: https://doi.org/10.1038/nature10238

Favre, I.; Moczydlowski, E.; Schild, L. On the structural basis for ionic selectivity among Na+, K+, and Ca2+ in the voltagegated sodium channel. Biophys J 1996, 71, 3110-3125, doi:10.1016/s0006-3495(96)79505-x. DOI: https://doi.org/10.1016/S0006-3495(96)79505-X

Egri, C.; Vilin, Y.Y.; Ruben, P.C. A thermoprotective role of the sodium channel β1 subunit is lost with the β1 (C121W) mutation. Epilepsia 2012, 53, 494-505, doi:10.1111/j.1528-1167.2011.03389.x. DOI: https://doi.org/10.1111/j.1528-1167.2011.03389.x

Brackenbury, W.J.; Isom, L.L. Na Channel β Subunits: Overachievers of the Ion Channel Family. Front Pharmacol 2011, 2, 53, doi:10.3389/fphar.2011.00053. DOI: https://doi.org/10.3389/fphar.2011.00053

Catterall, W.A. Structure and function of voltage-gated sodium channels at atomic resolution. Exp Physiol 2014, 99, 35-51, doi:10.1113/expphysiol.2013.071969. DOI: https://doi.org/10.1113/expphysiol.2013.071969

Eijkelkamp, N.; Linley, J.E.; Baker, M.D.; Minett, M.S.; Cregg, R.; Werdehausen, R.; Rugiero, F.; Wood, J.N. Neurological perspectives on voltage-gated sodium channels. Brain 2012, 135, 2585-2612, doi:10.1093/brain/aws225. DOI: https://doi.org/10.1093/brain/aws225

Lampert, A.; Eberhardt, M.; Waxman, S.G. Altered sodium channel gating as molecular basis for pain: contribution of activation, inactivation, and resurgent currents. Handb Exp Pharmacol 2014, 221, 91-110, doi:10.1007/978-3-642-41588-3_5. DOI: https://doi.org/10.1007/978-3-642-41588-3_5

Jarecki, B.W.; Piekarz, A.D.; Jackson, J.O., 2nd; Cummins, T.R. Human voltage-gated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currents. J Clin Invest 2010, 120, 369-378, doi:10.1172/jci40801. DOI: https://doi.org/10.1172/JCI40801

Black, J.A.; Waxman, S.G. Noncanonical roles of voltage-gated sodium channels. Neuron 2013, 80, 280-291, doi:10.1016/j.neuron.2013.09.012. DOI: https://doi.org/10.1016/j.neuron.2013.09.012

Catterall, W.A.; Kalume, F.; Oakley, J.C. NaV1.1 channels and epilepsy. J Physiol 2010, 588, 1849-1859, doi:10.1113/jphysiol.2010.187484. DOI: https://doi.org/10.1113/jphysiol.2010.187484

Meisler, M.H.; Kearney, J.A. Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest 2005, 115, 2010-2017, doi:10.1172/jci25466. DOI: https://doi.org/10.1172/JCI25466

George, A.L., Jr. Inherited disorders of voltage-gated sodium channels. J Clin Invest 2005, 115, 1990-1999, doi:10.1172/jci25505. DOI: https://doi.org/10.1172/JCI25505

Barela, A.J.; Waddy, S.P.; Lickfett, J.G.; Hunter, J.; Anido, A.; Helmers, S.L.; Goldin, A.L.; Escayg, A. An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability. J Neurosci 2006, 26, 2714-2723, doi:10.1523/jneurosci.2977-05.2006. DOI: https://doi.org/10.1523/JNEUROSCI.2977-05.2006

Rusconi, R.; Scalmani, P.; Cassulini, R.R.; Giunti, G.; Gambardella, A.; Franceschetti, S.; Annesi, G.; Wanke, E.; Mantegazza, M. Modulatory Proteins Can Rescue a Trafficking Defective Epileptogenic Na_v1.1 Na⁺ Channel Mutant. The Journal of Neuroscience 2007, 27, 11037-11046, doi:10.1523/jneurosci.3515-07.2007. DOI: https://doi.org/10.1523/JNEUROSCI.3515-07.2007

Claes, L.; Del-Favero, J.; Ceulemans, B.; Lagae, L.; Van Broeckhoven, C.; De Jonghe, P. De novo mutations in the sodiumchannel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001, 68, 1327-1332, doi:10.1086/320609. DOI: https://doi.org/10.1086/320609

The Center for Molecular Neurology. The Variation Database of SCN1A. Available online: http://www.molgen.ua.ac.be/SCN1AMutations/Statistics/Mutations.cfm (accessed on 28.08.2018).

Catterall, W.A.; Dib-Hajj, S.; Meisler, M.H.; Pietrobon, D. Inherited neuronal ion channelopathies: new windows on complex neurological diseases. J Neurosci 2008, 28, 11768-11777, doi:10.1523/jneurosci.3901-08.2008. DOI: https://doi.org/10.1523/JNEUROSCI.3901-08.2008

Misra, S.N.; Kahlig, K.M.; George, A.L., Jr. Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatal-infantile seizures. Epilepsia 2008, 49, 1535-1545, doi:10.1111/j.1528-1167.2008.01619.x. DOI: https://doi.org/10.1111/j.1528-1167.2008.01619.x

Holland, K.D.; Kearney, J.A.; Glauser, T.A.; Buck, G.; Keddache, M.; Blankston, J.R.; Glaaser, I.W.; Kass, R.S.; Meisler, M.H. Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy. Neurosci Lett 2008, 433, 65-70, doi:10.1016/j.neulet.2007.12.064. DOI: https://doi.org/10.1016/j.neulet.2007.12.064

Ragsdale, D.S. How do mutant Nav1.1 sodium channels cause epilepsy? Brain Res Rev 2008, 58, 149-159, doi:10.1016/j.brainresrev.2008.01.003. DOI: https://doi.org/10.1016/j.brainresrev.2008.01.003

Yu, F.H.; Mantegazza, M.; Westenbroek, R.E.; Robbins, C.A.; Kalume, F.; Burton, K.A.; Spain, W.J.; McKnight, G.S.; Scheuer, T.; Catterall, W.A. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 2006, 9, 1142-1149, doi:10.1038/nn1754. DOI: https://doi.org/10.1038/nn1754

Patyra, A. Badanie elektrofizjologiczne nerwów obwodowych u dzieci z zespołem padaczkowym Dravet. Medical University of Warsaw, Warsaw, Poland, 2018.

Andrzej Patyra

andrzej.patyra@wum.edu.pl
https://orcid.org/0000-0003-4981-6660

Afiliacja:

Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of Warsaw, Warsaw, Poland; Doctoral School, Medical University of Warsaw, Warsaw, Poland; Institut des Biomolécules Max Mousseron, Université de Montpellier, CNRS, ENSCM, Montpellier, France Poland

Grzegorz Witkowski

Afiliacja:

I-st Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland Poland